20.7 C
New York

Tag: Almost

Claudin18.2, a shining star in gastric cancer, Transcenta’s TST001 stands at the global forefront

HONG KONG, Sept 28, 2022 - (ACN Newswire) - Transcenta Holding Limited (06628.HK), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of...

Top News

Report Says Binance Shared Client Data With Russia, Crypto Exchange Denies Allegations

Cryptocurrency exchange Binance has been accused in a media report of agreeing to provide user data to Russia’s financial watchdog. The trading platform has...

Bitcoin (BTC) Perpetual Contract Price Analysis: April 24

On April 24, the bullish BTC price analysis is at  $48316.69. BTC’s bearish market price analysis for April 24, 2022, is $33155.06. Bitcoin’s...

Beyond Imagination’s New Humanoid Robot Will Connect People Coast to Coast Physically

Tag Template - News Hub PRO CoinGenius Hosts Virtual Crypto Event The Road To Mass Adoption

NEW YORK, Apr 22, 2022 - (ACN Newswire) - Beyond Imagination, Inc. is building humanoid robots to solve the world's labor crisis by expanding access to jobs around the globe.

This week, the Beomni robot will appear at Explorers Club Headquarters and at the annual dinner on Saturday April 23rd in New York City. At the same time, across the country in Beverly Hills, CA, attendees at the Abundance360 Annual Summit will be able to remotely pilot the robot from 2,800 miles away.

Beomni is the world's most sophisticated general-purpose humanoid robot, capable of performing an almost unlimited number of tasks. Beomni's AI Brain learns from its human pilots and becomes increasingly autonomous over time.

Beomni will help solve the labor crisis by creating a global elastic labor force, lifting millions of people out of poverty by giving them access to jobs around the world. For example, the International Labour Organization (ILO) reports that "More than 2.3 million workers die every year as a result of occupational accidents or work-related diseases." With Beomni, dangerous work will become completely safe because the robot will be the one taking the risks.

Elder Care is a $932B market today. We will help solve the elder crisis by enabling families to care for their own regardless of the distance between them and by multiplying the effectiveness of existing health care workers.

CEO and Founder Dr. Harry Kloor says, "We are thrilled to have been invited to demonstrate the advances we've made in Beomni's development at the Explorers Club. Beomni will be a great vehicle for explorers on earth and beyond! We share the spirit of exploration and discovery that is the hallmark of the Explorers Club."

Astronaut and Explorers Club President Richard Garriott adds, "For the last decade, I have been a power USER of early telepresence robotics devices, so I deeply appreciate the advancements in Beomni. We welcome the opportunity to showcase Dr. Kloor's creation alongside other world-changing technologies at our event. Smart technologies like Beomni will play an important part in helping solve the challenges the world is facing. On Earth, in space and on planets beyond Earth, robots like Beomni will play an essential role!"

The robot will be on display all week at the Explorers Club headquarters so members can have an opportunity to pilot it. On Saturday, Beomni will move to The Glass House, where the annual dinner is being held. Beomni will be serving drinks and hors d'oeuvres at the reception, and at the afterparty guests will also have the opportunity to pilot the robot.

Meanwhile, across the country in Beverly Hills, a second Beyond Imagination team will be set up at the Abundance360 Annual Summit. From there, Beomni will be operated from coast to coast. Members in attendance at the A360 Summit will be able to perform tasks, pick up and examine objects and even shake someone's hand across the country.

Abundance360 Founder, Peter Diamandis remarked, "Beyond Imagination dramatically changes the paradigm of how companies will provide services in the future, how and where you will receive healthcare, where you work and play."

About Beyond Imagination, Inc.

Beyond Imagination is a robotics and AI platform company that is focused on bringing humanoid robots to market rapidly. By partnering a human pilot with an evolving AI Brain, we will soon be able to deploy our Beomni Robotics platform across a wide range of commercial applications. Our practical, real-world approach is closer to that of Tesla, which released its vehicles and then built AI from the data that they collected, rather than that of other companies that are focused on narrow R&D domains.

Founded by leading innovators in AI and robotics, and strengthened by a solid patent portfolio, Beyond Imagination, Inc. is poised to revolutionize life and fundamentally change the way we work, travel and engage with others around the world.

Beyond Imagination is actively seeking business partners and investors for its Series A round. Details will be provided to qualified investors upon request. In-person demos are available by appointment for media and investors. Beyond Imagination is also seeking additional partners for pilot studies in medicine and beyond.

About The Explorers Club

Since its inception in 1904, members of the Club have traversed the earth, the seas, the skies, and even the moon, on expeditions. First to the North Pole, first to the South Pole, first to the summit of Mount Everest, first to the deepest point in the ocean and first to the surface of the moon - all accomplished by Explorers Club Members. Notable members include Teddy Roosevelt, Neil Armstrong, Jane Goodall, Edmund Hillary, John Glenn, Sally Ride, Bob Ballard, and more. https://www.explorers.org/

For more information visit: https://www.beomni.ai/

Source: Plato Data Intelligence

Copyright 2022 ACN Newswire. All rights reserved. www.acnnewswire.comBeyond Imagination, Inc. is building humanoid robots to solve the world's labor crisis by expanding access to jobs around the globe.

What triggered AVAX’s recent 10% correction and its significance in the near-term

Tag Template - News Hub PRO CoinGenius Hosts Virtual Crypto Event The Road To Mass AdoptionAvalanche, facing the brunt of the bears, has noted an almost 11% drop in the last 24 hours. Although, the altcoin has been losing more than other coins for more than a week now. It took a break to post one green candle when the news of Terra choosing Avalanche for backing UST came out. […]

ARMA International Forms Global Partnership With The Records and Information Management Professionals Australasia

Tag Template - News Hub PRO CoinGenius Hosts Virtual Crypto Event The Road To Mass Adoption

LEE'S SUMMIT, MO and BURLEIGH HEADS, AU, Apr 8, 2022 - (ACN Newswire) - ARMA International (www.arma.org), the world's leading membership organization serving professionals who manage and govern information assets and the Records and Information Management Professionals Australasia (RIMPA) (www.rimpa.com.au/), the longest serving peak body for industry practitioners in the southern hemisphere announced today a Global Partnership to better serve the information management profession worldwide.

The global partnership between these two leading worldwide organizations will provide many benefits to their collective 7,000 members who will now have the opportunity for joint membership in both organizations; access to reciprocal resources including communities and professional development, education and certifications; and advocacy for the information management and information governance profession. Together the two organizations will work together to provide a unique perspective on global information issues.

"Increasing the influence of the organization in the information management profession globally is a key strategic goal put forth by the ARMA Board of Directors. A partnership between ARMA and RIMPA is an amazing opportunity to create a global alliance for the industry and increase the opportunities for all of our members worldwide," added Michael Haley, President, Board of Directors, ARMA.

"Information management and recordkeeping is a global challenge to do well. For the benefit of world citizens, I see the ARMA and RIMPA alliance as a very important step in meeting this challenge through the exchange of information, sharing resources and good will and I am very proud to part of this exciting journey that we are about to embark on," said Thomas Kaufhold, Chair of Board, RIMPA.

The two organizations have already begun collaborating. Nathan Hughes, Executive Director of ARMA and Wendy McLain, President-Elect of ARMA will be attending the RIMPA Live 2022 Convention, June 14-17 in Canberra, Australia, and participate in meetings with the RIMPA Board. Anne Cornish, Chief Executive Officer of RIMPA and Thomas Kaufhold, Chair of the Board of RIMPA will be attending ARMA's InfoCon 2022, October 16-19, in Nashville, TN, and participate in meetings with the ARMA Board.

"The partnership of ARMA and RIMPA brings with it the opportunity to integrate two of the largest information management communities to continue to increase awareness for the industry. The possibilities expand exponentially when like-minded organizations work globally for their membership and foster an environment of growth," said Nathan Hughes, Executive Director, ARMA.

"A RIMPA and ARMA alliance provide both member groups with the opportunity to broaden their knowledge and extend networking opportunities. Working together on global issues and increasing access to professional development opportunities and resources is a positive sign of how society can operate effectively in separate hemispheres," added Anne Cornish, Chief Executive Officer, RIMPA.

About ARMA International

ARMA International (www.arma.org), formed in 1955, is the world's leading membership organization serving almost 5,000 professionals who manage and govern information in 52 countries. Members represent the community of records management, information management, and information governance professionals who harness the benefits and reduce the risks of information. ARMA provides information professionals with the resources, tools, and training they need to effectively manage records and information within an established information governance framework. Works that are associated with the framework include the Principles, the Information Governance Maturity Model and the Information Governance Body of Knowledge (IGBOK). ARMA recognizes professionals who have mastered these concepts through the Information Governance Professional (IGP) Certification.

About The Records and Information Management Professionals Australasia

The Records and Information Management Professionals Australasia (RIMPA) (www.rimpa.com.au/) established in 1969, represents over 2,000 professionals and organizations in the private sector, Commonwealth, Federal, State and Local Governments. RIMPA has active Branches and Chapters operating in all states and territories across Australia and New Zealand. RIMPA is the longest serving peak body for industry practitioners in the southern hemisphere and actively promotes best practice, sets industry standards and fosters professional development across all business sectors and educational institutions. Through its international partnerships with other peak bodies, RIMPA provides its members with access to an accomplished framework of professional associations. RIMPA has strategic alliances with the Information Governance ANZ, Institute of Managers and Leaders (IML), Australian Library and Information Association (ALIA), Australian Society of Archivist (ASA) and Leadership Through Data.

For further information, contact:
Amy Riemer, Media Relations Representative
978-475-4441 (office) or 978-502-4895 (cell)
amy@riemercommunications.com

SOURCE: ARMA International

Copyright 2022 ACN Newswire. All rights reserved. www.acnnewswire.comARMA International (www.arma.org), the world's leading membership organization serving professionals who manage and govern information assets and the Records and Information Management Professionals Australasia (RIMPA) (www.rimpa.com.au/), the longest serving peak body for industry practitioners in the southern hemisphere announced today a Global Partnership to better serve the information management profession worldwide.

What Bitcoiners Need to Know About Jury Nullification In A Hostile Legal System

Jury nullification is one tool that may be needed if antagonistic policies get passed which lead to Bitcoin users being labeled as criminals.
Tag Template - News Hub PRO CoinGenius Hosts Virtual Crypto Event The Road To Mass Adoption

Bitcoin Barbed Wire And The Crypto Anarchist Manifesto

Comparing Bitcoin to barbed wire from Timothy May’s “Crypto Anarchist Manifesto” can give insight into the gravity of this seemingly abstract invention.

Official Listing of Recbio on HKEX, Vaccine Innovation and Iteration Accelerated by Novel Adjuvant Technology

HONG KONG, Apr 1, 2022 - (ACN Newswire) - On March 31, the China-based novel vaccines company - Jiangsu Recbio Technology Co., Ltd. ("Recbio" or the "Company", Stock Code: 2179.HK) went public and was officially listed on the Hong Kong Stock Exchange. Assuming the Over-allotment option is not exercised, 30,854,500 H shares were issued under the Global Offering, with a price of HK$24.80 per share and proceeds up to approximately HK$765 million. The Hong Kong public Offering received an enthusiastic response from investors and was over-subscribed by more than 9.65 times. As the cornerstone investors of the Company, the cornerstone subscription ratios of Yangtze River Pharmaceutical, Harvest Global and Sequoia China exceed 50%. Previously, the Company has won the favor of many well-known investment institutions, including Legend Capital, LYFE Capital, Oriental Fortune Capital, Fer-Capital, Sequoia China, CMB International, Lake Bleu and Temasek. Having successfully listed in Hong Kong, becoming "the first HPV vaccine stock in Hong Kong" and "the first novel adjuvant vaccine stock in Hong Kong", Recbio is expected to inject new vitality into the capital market in Hong Kong.

Tag Template - News Hub PRO CoinGenius Hosts Virtual Crypto Event The Road To Mass Adoption

Tag Template - News Hub PRO CoinGenius Hosts Virtual Crypto Event The Road To Mass Adoption

Tag Template - News Hub PRO CoinGenius Hosts Virtual Crypto Event The Road To Mass Adoption
Chart: Innovative vaccine portfolio of Recbio

Tag Template - News Hub PRO CoinGenius Hosts Virtual Crypto Event The Road To Mass Adoption

Domestic vaccine innovation and iteration accelerated by novel adjuvant technology

Vaccines are praised as the "golden track" in the medical health field. According to the Frost & Sullivan report, from 2016 to 2020, the size of the global vaccine market has increased from US$27.5 million to US$39.9 billion at a CAGR of 9.7%, while the CAGR of global pharmaceutical market was only 3.02%. China has become the second largest vaccine market globally, with the market volume increased from RMB27.1 billion in 2016 to RMB75.3 billion in 2020 at a CAGR of 29.1%.

Regarding the insufficient domestic supply of and the unmet urgent demand for novel vaccines, it has become an important part of the Development Planning of the Pharmaceutical Industry in the "14th Five-Year Plan" in China (referred as the "Plan") to promote enterprises to speed up the development of related products and to achieve product availability as soon as possible. Regarding the development of the vaccine industry, the "Plan" also states that research and development of novel vaccines (such as novel adjuvants for vaccines and mRNA vaccines) and building of industrialization capability shall be accelerated. It also emphasizes on the development of novel COVID-19 vaccines, herpes vaccines, polyvalent human papillomavirus (HPV) vaccines and other products.

As an innovative novel vaccine company, Recbio has constructed the three core technology platforms consisting of novel adjuvants, protein engineering and immunological evaluation, forming synergy in antigen design and optimization, adjuvant development and production, identification of the best combination of antigen and adjuvants. The Company has built a comprehensive and high-valued vaccine portfolio consisting of 12 candidates, covering cervical cancer, COVID-19, adult tuberculosis, shingles, HFMD, influenza etc. It covers five of the ten diseases with the greatest burden under the 2019 Global Burden of Diseases issued by the World Health Organization and disease areas of the three of the top five globally bestselling vaccine products in 2020.

Novel adjuvant for vaccines is the "bottleneck" technology of innovative vaccines. Through years of technical research, Recbio has successfully achieved independent control of all FDA-approved novel adjuvants, and is one of the few companies in the world capable of independent development of novel adjuvants. It has also successfully applied in various innovative vaccines such as COVID-19 vaccines, HPV vaccines and shingles vaccines.

A moat constructed with a rich product portfolio

HPV vaccines are one of the most commercially valuable vaccines in the world. It is expected that there will be 234 million females in China aged 9-45 unvaccinated for HPV in 2025 assuming 3 doses per person, requiring additional 702 million doses. Currently, Recbio has formed a full coverage of bivalent, quadrivalent and 9-valent vaccines and novel adjuvant upgrades in the field of HPV vaccines. The core product REC603, a recombinant HPV 9-valent vaccine is currently under phase III clinical trial, expected to become the first approved domestic HPV 9-valent vaccine. Regarding the global immunization program market, REC601, a bivalent vaccine has the potential to become one of the most popular vaccine options. At the same time, the Company is also in the process of developing second-generation HPV vaccines, namely REC604a (a quadrivalent vaccine) and REC604b (a 9-valent vaccine). Both vaccines have adopted our self-developed novel adjuvants and are expected to achieve two-shot regimens in the future. The construction of the first phase of the HPV manufacturing facility of Recbio is expected to be completed by the end of this year. By then, it will realize the designed capacity of five million doses of HPV 9-valent vaccines or 30 million doses of HPV bivalent vaccines per year. As the first cancer preventive vaccine in the world, HPV vaccines have been in shortage for a long time. With the gradual release of domestic HPV vaccines in the future and the gradual release of production capacity, domestic substitution will be accelerated.

Protein engineering, novel adjuvant and other technology are comprehensively used in ReCOV, the COVID-19 vaccine of Recbio, to thoroughly optimize the vaccine, allowing ReCOV to possess a series of comprehensive advantages, including excellent safety, strong immunogenicity, strong cross-protection effectiveness with Omicron and Delta mutant strains, easy-to-scale-up production, low production cost, high preparation stability, storage and transportation in room temperature etc. The international phase II/III clinical trials of such vaccine are currently in progress. EUA/BLA applications are estimated to be submitted in 2022. On the side of production supply, the Company has completed the construction of our GMP-standard manufacturing facility for ReCOV and obtained the drug production license in November 2021. The manufacturing facility has a total GFA of approximately 17,000 sq.m., has the potential to support an annual manufacturing capacity of 300 million doses of ReCOV and can be used to manufacture recombinant shingles vaccines.

In the field of shingles vaccines, shingles virus is dormant in almost all adults over 50 of age in China, affecting approximately 2.5 million adults in China every year. However, Shingrix is currently the only shingles vaccine approved in China. The novel adjuvant which benchmarking AS01 is adopted in REC610 of the Company, significantly improving vaccine immunogenicity, hoping to achieve domestic substitution quickly.

Recogen, our subsidiary has first achieved technology breakthrough in lyophilized mRNA vaccines. It has applied the self-developed freeze-drying technology to achieve preparation stability at 4 degrees Celsius and 25 degrees Celsius, allowing storage and transportation under general cold-chain conditions, effectively solving the current defect in availability of mRNA vaccines.

"We are glad that the Hong Kong stock IPO has been highly recognized by the capital market. The successful listing of Recbio is expected to bring more confidence to the Hong Kong 18A stock market. Thanks to all the investors for their strong support, we were able to successfully go public as originally planned in such extremely depressed environment of the Hong Kong capital market!" Regarding the listing of Recbio in Hong Kong, Dr. Liu Yong, the Founder, Chairman of the Board, and General Manager of Recbio stated that, "Against the backdrop of a huge global demand for innovative vaccines in this era, through continuous innovation and international cooperation, we will accelerate the commercialization of products in the global market, promote innovation in the entire value chain of the vaccine industry from R&D to commercialization, and create greater value for shareholders and investors. Today is the beginning of a brand-new journey for Recbio. I hope that all investors will continue to support our Company. Let's hope we will continue to move forward hand in hand, through the sweltering summer and winter, and create new glory together!"

About Recbio
Founded in 2012, Recbio is an innovative vaccine company with independent research and development technology as its core driving force. It is committed to building a full value chain of innovative vaccines, covering research and development, production and commercialization. The Company has always adhered to the mission of "creating first-class vaccines and protecting human health". With a strong research and development engine comprising of novel adjuvants, protein engineering, immunological evaluation and other core technology platforms, strategically focusing on disease areas with significant burden such as cervical cancers COVID-19, shingles, adult TB, HFMD and flu etc., the Company has established a high-value product pipeline consisting of 12 vaccine candidates with independent intellectual property rights, in order to meet the under-fulfilled public health needs. For more information, please visit https://www.recbio.cn/.


Copyright 2022 ACN Newswire. All rights reserved. www.acnnewswire.comOn March 31, the China-based novel vaccines company - Jiangsu Recbio Technology Co., Ltd. ("Recbio" or the "Company", Stock Code: 2179.HK) went public and was officially listed on the Hong Kong Stock Exchange.

Fullerton Fund Management appoints Ken Goh as Chief Investment Officer

Tag Template - News Hub PRO CoinGenius Hosts Virtual Crypto Event The Road To Mass Adoption

Singapore, Apr 1, 2022 - (ACN Newswire) - Fullerton Fund Management ("Fullerton") has appointed Ken Goh as Chief Investment Officer (CIO), effective 1 April 2022. Ken will report to Jenny Sofian, Chief Executive Officer (CEO).

Tag Template - News Hub PRO CoinGenius Hosts Virtual Crypto Event The Road To Mass Adoption
Mr. Ken Goh, CFA, Chief Investment Officer

As CIO, Ken will be steering the strategic direction for Fullerton's investment team. He will also oversee investment performance for all portfolios across equities, fixed income, alternatives, multi-asset and treasury management.

"Ken's appointment comes at an important time, as we grow our business and respond to the changing environment, as well as needs of clients. Ken's proven abilities, astute leadership and portfolio management expertise will be instrumental in driving the expansion of our investment capabilities to deliver investment excellence to clients," said Jenny Sofian, CEO.

Prior to his new role, Ken was Deputy CIO and Head of Equities at Fullerton. An industry veteran with almost 30 years of investment experience, he has deep and extensive expertise in managing portfolios and leading teams across different market cycles. At Fullerton, he spearheaded enhancements to investment processes and strategies, focusing on a high conviction, ESG-integrated investment approach. He was also instrumental in reinforcing the investment architecture at Fullerton, by driving collaboration across teams and investment platforms, and through the articulation of house views.

Before joining Fullerton in 2017, Ken held senior portfolio management and leadership positions at several local and international firms. His wealth of experience and tenacity makes him an ideal candidate to lead Fullerton's investment team.

"I am very excited to take on this role and work closely with our seasoned investment team to take advantage of market opportunities and drive investment growth for our clients," Ken said. "We have deep bench strength in the asset classes that we manage, and I am confident that our deep understanding of markets, strong investment platforms, and integrated, collaborative culture can unlock substantial value for investors."

Ken succeeds Patrick Yeo, who will be leaving Fullerton after 17 years. Patrick will remain at Fullerton till September, and will work with Ken and the investment team to ensure a seamless transition.

"We would like to thank Patrick for his contributions to Fullerton, and the role he has played in growing the core capabilities of the firm. We wish him well in his future endeavours," Jenny said.

About Fullerton Fund Management

Fullerton Fund Management Company Ltd ("Fullerton") is an Asia-based investment specialist, focused on optimising investment outcomes and enhancing investor experience. We help clients, including government entities, sovereign wealth funds, pension plans, insurance companies, private wealth and retail, from the region and beyond, to achieve their investment objectives through our suite of solutions.

Our expertise encompasses equities, fixed income, multi-asset, alternatives and treasury management, across public and private markets. As an active manager, we place strong emphasis on performance, risk management and investment insights.

Incorporated in 2003, Fullerton is headquartered in Singapore, and has associated offices in Shanghai, London, and Brunei. Fullerton is part of a multi-asset management group, Seviora, a holding company established by Temasek. NTUC Income, a leading Singapore insurer, is a minority shareholder of Fullerton.

For more information, please visit www.fullertonfund.com

Biography

Mr Ken Goh, CFA
Chief Investment Officer

Ken is CIO at Fullerton Fund Management. He sets the strategic direction for the investment team and is responsible for overseeing the investment performance of all portfolios. Ken also manages Fullerton's Global Absolute Alpha, Asia Focus and Asia Absolute Alpha Equities strategies.

Ken joined Fullerton in 2017 as Head of Equities and was additionally appointed Deputy CIO in 2020. He was previously CEO of CIMB Principal Asset Management's Singapore office. He was also concurrently Regional CIO and Regional Head of Equities. Before he joined CIMB Principal in 2007, he held various senior positions in APS Asset Management, MeesPierson Private Bank, Allianz Dresdner Asset Management and Philip Capital Management. Earlier in his career, Ken worked at the Government of Singapore Investment Corporation (GIC).

Ken graduated from National University of Singapore with a First-Class Honours in Business Administration. He is also a CFA charterholder.

For media queries, please contact:
Kamal Samuel
Email: fullerton@financialpr.com.sg
Mobile: 92294410

Copyright 2022 ACN Newswire. All rights reserved. www.acnnewswire.comFullerton Fund Management has appointed Ken Goh as Chief Investment Officer (CIO), effective 1 April 2022. Ken will report to Jenny Sofian, Chief Executive Officer (CEO).

Ariva Mentioned as Top Project in Blockchain for Travel Summit in Dubai

Tag Template - News Hub PRO CoinGenius Hosts Virtual Crypto Event The Road To Mass AdoptionPRESS RELEASE. Fast-growing blockchain protocol Ariva was highlighted as one of the key drivers of blockchain technology in the tourism sector at the Blockchain For Travel Summit held in Dubai on March 26, 2022. A gathering of key stakeholders in the tourism sector for blockchain ‘’The Global Tourism Forum Blockchain for Travel Summit’’ was organized […]

Bitcoin Is Venice: Wrestling With The Truth

Surprising as it may be, Bitcoin’s history mirrors the history of mixed martial arts.

Bitcoin Is On FIRE

The ethos of living frugally and investing wisely only gets better when applied to a bitcoin standard.
Tag Template - News Hub PRO CoinGenius Hosts Virtual Crypto Event The Road To Mass Adoption

Recent articles

spot_img